Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2010
Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memoryGrégoire Jeannet, Caroline Boudousquié, Noémie Gardiol, et al.Current Opinion in Biotechnology|April 26, 2020
Are dendritic cells the most appropriate therapeutic vaccine for patients with ovarian cancer?Silvia Martin-Lluesma, Michele Graciotti, Alizée J Grimm, et al.International Immunology|December 3, 2010
CD4+CD25-mTGFbeta+ T cells induced by nasal application of ovalbumin transfer tolerance in a therapeutic model of asthmaCéline Pellaton-Longaretti, Caroline Boudousquié, Nathalie Barbier, et al.Vaccines|January 18, 2020
Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell VaccineCaroline Boudousquié, Valérie Boand, Emilie Lingre, et al.Clinical and Translational Allergy|June 4, 2013
Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptidesCéline Pellaton, Yannick Perrin, Caroline Boudousquié, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2014
Differences in the transduction of canonical Wnt signals demarcate effector and memory CD8 T cells with distinct recall proliferation capacityCaroline Boudousquié, Maxime Danilo, Laurène Pousse, et al.International Journal of Inflammation|July 5, 2012
Intragastric and Intranasal Administration of Lactobacillus paracasei NCC2461 Modulates Allergic Airway Inflammation in MiceCéline Pellaton, Sophie Nutten, Anne-Christine Thierry, et al.Journal of Translational Medicine|November 28, 2019
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinomaApostolos Sarivalasis, Caroline Boudousquié, Klara Balint, et al.Cytotherapy|October 18, 2020
Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environmentPhilippe O Gannon, Alexandre Harari, Aymeric Auger, et al.Pageof 1